|
1
|
Watanabe T, Muro K, Ajioka Y, Hashiguchi
Y, Ito Y, Saito Y, Hamaguchi T, Ishida H, Ishiguro M, Ishihara S,
et al: Japanese society for cancer of the colon and rectum (JSCCR)
guidelines 2016 for the treatment of colorectal cancer. Int J Clin
Oncol. 23:1–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Horvat N, Carlos Tavares Rocha C, Clemente
Oliveira B, Petkovska I and Gollub MJ: MRI of rectal cancer: Tumor
staging, imaging techniques, and management. Radiographics.
39:367–387. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eglinton T, Luck A, Bartholomeusz D,
Varghese R and Lawrence M: Positron-emission tomography⁄computed
tomography (PET⁄CT) in the initial staging of primary rectal
cancer. Colectal Dis. 12:667–673. 2010. View Article : Google Scholar
|
|
4
|
Gearhart SL, Frassica D, Rosen R, Choti M,
Schulick R and Wahl R: Improved staging with pretreatment positron
emission tomography/computed tomography in low rectal cancer. Ann
Surg Oncol. 13:397–404. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nahas CS, Akhurst T, Yeung H, Leibold T,
Riedel E, Markowitz AJ, Minsky BD, Paty PB, Weiser MR, Temple LK,
et al: Positron emission tomography detection of distant metastatic
or synchronous disease in patients with locally advanced rectal
cancer receiving preoperative chemoradiation. Ann Surg Oncol.
15:704–711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bang JI, Ha S, Kang SB, Lee KW, Lee HS,
Kim JS, Oh HK, Lee HY and Kim SE: Prediction of neoadjuvant
radiation chemotherapy response and survival using pretreatment
[18F]FDG PET/CT scans in locally advanced rectal cancer. Eur J Nucl
Med Mol Imaging. 43:422–431. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shanmugan S, Arrangoiz R, Nitzkorski JR,
Yu JQ, Li T, Cooper H, Konski A, Farma JM and Sigurdson ER:
Predicting pathological response to neoadjuvant chemoradiotherapy
in locally advanced rectal cancer using 18FDG-PET/CT. Ann Surg
Oncol. 19:2178–2185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krug B, Crott R, de Cannière L, D'Hondt L
and Vander Borght T: A systematic review of the predictive value of
18F-fluoro 2-deoxyglucose positron emission tomography on survival
in locally advanced rectal cancer after neoadjuvant chemoradiation.
Colorectal Dis. 15:e627–e633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tahara N, Tahara A, Honda A, Nitta Y,
Kodama Y and Fukumoto Y: Cardiac FDG-PET examinations. Heart.
45:1220–1228. 2013.(Article In Japanese).
|
|
10
|
Yoshinaga K, Naya M, Shiga T, Suzuki E and
Tamaki N: Ischaemic memory imaging using metabolic
radiopharmaceuticals: Overview of clinical settings and ongoing
investigations. Eur J Nucl Med Mol Imaging. 41:384–393. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dou KF, Xie BQ, Gao XJ, Li Y, Yang YJ, He
ZX and Yang MF: Use of resting myocardial 18F-FDG imaging in the
detection of unstable angina. Nucl Med Commun. 36:999–1006. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Groot M, Meeuwis AP, Kok PJ, Corstens
FH and Oyen WJ: Influence of blood glucose level, age and fasting
period on non-pathological FDG uptake in heart and gut. Eur J Nucl
Med Mol Imaging. 32:98–101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nose H, Otsuka H, Otomi Y, Terazawa K,
Takao S, Iwamoto S, Iwase T, Yamada H, Sata M and Harada M: The
physiological uptake pattern of 18F-FDG in the left ventricular
myocardium of patients without heart disease. J Med Invest.
61:53–58. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Inglese E, Leva L, Matheoud R, Sacchetti
G, Secco C, Gandolfo P, Brambilla M and Sambuceti G: Spatial and
temporal heterogeneity of regional myocardial uptake in patients
without heart disease under fasting conditions on repeated
whole-body 18F-FDG PET/CT. J Nucl Med. 48:1662–1669. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saigusa S, Toiyama Y, Tanaka K, Okugawa Y,
Fujikawa H, Matsushita K, Uchida K, Inoue Y and Kusunoki M:
Prognostic significance of glucose transporter-1 (GLUT1) gene
expression in rectal cancer after preoperative chemoradiotherapy.
Surg Today. 42:460–469. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okumura N, Okada Y, Kumai K, Hosokawa T,
Oonuma J, Takata Y and Ito M: The changes in the 18F FDG
metabolism in the muscles by the use of cuboid support insoles.
Indian J Nucl Med. 37:178–185. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsushita K, Uchida K, Saigusa S, Ide S,
Hashimoto K, Koike Y, Otake K, Inoue M, Tanaka K and Kusunoki M:
Glycolysis inhibitors as a potential therapeutic option to treat
aggressive neuroblastoma expressing GLUT1. J Pediatr Surg.
47:1323–1330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu L, Qiu C, Wang X, Xu M, Shao X and Wang
Y: The association between diabetes mellitus and reduction in
myocardial glucose uptake: A population-based 18F-FDG
PET/CT study. BMC Cardiovasc Disord. 18:2032018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nuutinen J, Minn H, Bergman J, Haaparanta
M, Ruotasalainen U, Laine H and Knuuti J: Uncoupling of fatty acid
and glucose metabolism in malignant lymphoma: A PET study. Br J
Cancer. 80:513–518. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Heckmann MB, Totakhel B, Finke D, Anker
MS, Müller-Tidow C, Haberkorn U, Katus HA and Lehmann LH: Evidence
for a cardiac metabolic switch in patients with Hodgkin's lymphoma.
ESC Hear Fail. 6:824–829. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Choi MH, Oh SN, Lee IK, Oh ST and Won DD:
Sarcopenia is negatively associated with long-term outcomes in
locally advanced rectal cancer. J Cachexia Sarcopenia Muscle.
9:53–59. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okugawa Y, Toiyama Y, Yamaoto A, Shigemori
T, Ide S, Kitajima T, Fujikawa H, Yasuda Y, Hito J, Yoshiyama S, et
al: Lymphocyte-C-reactive protein ratio as promising new marker for
predicting surgical and oncological outcomes in colorectal cancer.
Ann Surg. 272:342–351. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shirai Y, Morita S, Iwata T, Nakai H,
Yoshikawa M, Yoshida K, Iwamoto H, Miyaji K, Okugawa Y, Miki C and
Tanaka K: Anti-inflammatory and nutritional improvement effects of
dietary supplementation combined with fish oil in patients with
epithelial cancer. Oncol Lett. 24:3062022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Okugawa Y, Shirai Y, Toiyama Y, Saigusa S,
Hishida A, Yokoe T, Tanaka K, Tanaka M, Yasuda Y, Fujikawa H, et
al: Clinical burden of modified glasgow prognostic scale in
colorectal cancer. Clinical burden of modified glasgow prognostic
scale in colorectal cancer. Anticancer Res. 38:1599–1610.
2018.PubMed/NCBI
|
|
27
|
Okugawa Y, Shirai Y, Nodono H, Matutani F,
Ito M, Hishida A, Morimoto Y, Nishikawa R, Yokoe T, Tanaka K, et
al: Objective predictive score as a feasible biomarker for
short-term survival in terminalIy Ill patients with cancer. Anti
Cancer Res. 37:267–275. 2017.
|
|
28
|
Hishida A, Yamada H, Ando Y, Okugawa Y,
Shiozawa M, Miyagi Y, Daigo Y, Toiyama Y, Shidai Y, Tanaka K, et
al: Investigation of miRNA expression profiles using cohort samples
reveals potential early detectability of colorectal cancers by
serum miR-26a-5p before clinical diagnosis. Oncol Lett. 23:872022.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang W, Ning N, Li X, Niu G, Bai L and
Guo Y: Changes of brain glucose metabolism in the pretreatment
patients with non-small cell lung cancer: A retrospective PET/CT
study. PLoS One. 11:e01613252016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fällmar D, Lilia J, Danfors T, Kilander L,
Iyer V, Lubberink M, Larsson EM and Sörensen M: Z-score maps from
low-dose 18F-FDG PET of the brain in neurodegenerative dementia. Am
J Nucl Med Mol Imaging. 8:239–246. 2018.PubMed/NCBI
|
|
31
|
Okada Y, Shiraishi M, Hori K, Yamaguchi K
and Hasegawa Y: Relationship between cerebral blood flow reduction
patterns on scintigraphy and nonmotor symptoms in new-onset Lewy
body disease. Nucl Med Rec Cent East Eur. 25:18–24. 2022.
View Article : Google Scholar : PubMed/NCBI
|
